Related Experiment Video
Updated: Aug 27, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Longitudinal Change in Disability and Functioning in Patients With Moderate-to-Severe Parkinson's Disease: A
Hsun-Hua Lee1,2,3, Lung Chan3,4, Wen-Chou Chi5
1Department of Neurology, Taipei Medical University Hospital, Taiwan.
Abstract:
Parkinson's disease (PD) is associated with progressive disability and declining functioning, yet longitudinal population-based evidence using standardized assessments remains limited. Using the Taiwan Databank of Persons with Disabilities, we identified patients with moderate-to-severe PD (Hoehn and Yahr stages III-V) who underwent baseline and follow-up World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) assessments within 1 to 5 years. Longitudinal changes were evaluated using repeated-measures analysis of covariance, and multivariable logistic regression identified factors associated with rapid progression, defined as an annual increase of at least 2 points. Among 2281 patients (mean follow-up, 2.9 ± 1.2 years), disability and functioning worsened significantly over time (P < .001), with an average annual increase of 1.87 points. Declines occurred across all domains except participation, with the greatest deterioration in getting along and cognition. Significant interactions were observed between age and cognition and between dementia status and mobility, self-care, and life activities. Rapid progression was independently associated with age ≥65 years (adjusted odds ratio [aOR] 1.776, 95% confidence interval [CI] 1.416-2.228) and dementia progression (aOR 1.826, 95% CI 1.345-2.478). These findings highlight substantial longitudinal deterioration in disability and functioning in moderate-to-severe PD, particularly in cognition, and support the importance of early functional assessment and identification of patients at high risk of rapid progression.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Alterations in Muscle Tone lll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology

